FDA Inspection
SriSai Biopharmaceutical Solutions LLCSriSai Biopharmaceutical Solutions LLC – FDA Inspection, Feb 23, 2023
Record Details
This FDA Inspection record concerns SriSai Biopharmaceutical Solutions LLC, with an inspection on February 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 66799cbe-df8a-49e7-9955-022702023f84
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1198226
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 212.40(b)Written specifications - components
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
- 21 CFR 212.40(b)Written specifications - components
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SriSai Biopharmaceutical Solutions LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SriSai Biopharmaceutical Solutions LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.